| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
CLOV
Clover Health Investments
|
Jun 11, 2026 | HOLD |
Hold
-29.7% avg upside
9 analysts
|
$4.75
5.06% Downside
|
· |
|
OSCR
Oscar Health
|
May 07, 2026 | HOLD |
Buy
-34.1% avg upside
15 analysts
|
$20.00
29.60% Downside
|
+35.4% |
|
EHTH
Ehealth
|
May 07, 2026 | HOLD |
Hold
+864.7% avg upside
19 analysts
|
$2.00
21.25% Upside
|
-7.0% |
|
ALHC
Alignment Healthcare
|
May 01, 2026 | HOLD |
Strong Buy
+1.2% avg upside
19 analysts
|
$22.00
0.56% Upside
|
-3.0% |
|
DH
Definitive Healthcare Corp
|
Aug 15, 2023 | HOLD |
Buy
+660.4% avg upside
19 analysts
|
$11.00
1347.45% Upside
|
-60.4% |
|
GOCOQ
GoHealth
|
Aug 11, 2023 | SELL |
Hold
+3607.1% avg upside
12 analysts
|
$10.00
2757.06% Upside
|
· |
|
GDRX
GoodRx Holdings
|
Aug 09, 2023 | HOLD |
Buy
+387.3% avg upside
28 analysts
|
$8.00
200.85% Upside
|
-9.2% |
|
LH
Labcorp Holdings
|
Jun 05, 2023 | BUY |
Strong Buy
+1.8% avg upside
36 analysts
|
$288.00
12.51% Upside
|
+7.3% |
|
MCK
McKesson
|
May 12, 2023 | BUY |
Strong Buy
-2.2% avg upside
27 analysts
|
$450.00
40.04% Downside
|
+44.4% |
|
AMN
AMN Healthcare Services
|
May 05, 2023 | BUY |
Buy
+35.2% avg upside
14 analysts
|
$115.00
271.20% Upside
|
-34.5% |
|
CCRN
Cross Country Healthcare
|
May 05, 2023 | HOLD |
Hold
+20.0% avg upside
15 analysts
|
$27.00
105.00% Upside
|
-29.1% |
|
AMWL
American Well
|
May 04, 2023 | HOLD |
Hold
+64.6% avg upside
15 analysts
|
$3.50
58.51% Downside
|
-71.4% |
|
CYH
Community Health
|
May 03, 2023 | HOLD |
Sell
+44.8% avg upside
18 analysts
|
$7.40
144.98% Upside
|
-5.5% |
|
COR
Cencora
|
May 03, 2023 | BUY |
Buy
+14.6% avg upside
43 analysts
|
$199.00
26.80% Downside
|
+35.6% |
|
EHC
Encompass Health
|
May 01, 2023 | BUY |
Strong Buy
+13.4% avg upside
22 analysts
|
$76.00
22.40% Downside
|
+30.0% |
|
ACHC
Acadia Healthcare
|
Apr 28, 2023 | BUY |
Strong Buy
+55.9% avg upside
17 analysts
|
$95.00
281.89% Upside
|
+1.8% |
|
MOH
Molina Healthcare
|
Apr 28, 2023 | BUY |
Buy
+13.8% avg upside
25 analysts
|
$350.00
79.09% Upside
|
+14.9% |
|
HCSG
Healthcare Services
|
Apr 28, 2023 | HOLD |
Buy
+5.5% avg upside
12 analysts
|
$17.00
25.81% Downside
|
-30.5% |
|
TDOC
Teladoc
|
Apr 27, 2023 | HOLD |
Buy
+257.6% avg upside
37 analysts
|
$27.00
234.47% Upside
|
-52.5% |
|
UHS
Universal Health
|
Apr 27, 2023 | BUY |
Buy
+50.5% avg upside
22 analysts
|
$163.00
15.44% Upside
|
+14.5% |
|
ACH
Accendra Health
|
Mar 07, 2023 | HOLD |
Hold
+439.4% avg upside
17 analysts
|
$17.00
426.24% Upside
|
+76.1% |
|
PRVA
Privia Health Group
|
Mar 07, 2023 | BUY |
Strong Buy
+33.8% avg upside
26 analysts
|
$41.00
73.21% Upside
|
-19.1% |
|
HIMS
Hims & Hers Health
|
Mar 01, 2023 | BUY |
Buy
-27.8% avg upside
22 analysts
|
$8.00
77.52% Downside
|
+13.8% |
|
HSIC
Henry Schein
|
Feb 28, 2023 | BUY |
Buy
+7.4% avg upside
25 analysts
|
$97.00
21.28% Upside
|
-2.3% |
|
SEM
Select Medical
|
Feb 27, 2023 | HOLD |
Buy
+28.1% avg upside
9 analysts
|
$29.00
75.26% Upside
|
+4.5% |
|
MD
Pediatrix Medical Group
|
Feb 22, 2023 | BUY |
Buy
-11.2% avg upside
14 analysts
|
$23.00
2.60% Downside
|
-46.2% |
|
SLQT
SelectQuote
|
Feb 21, 2023 | HOLD |
Buy
+685.6% avg upside
16 analysts
|
$3.00
203.59% Upside
|
-18.1% |
|
CAH
Cardinal Health
|
Feb 03, 2023 | HOLD |
Strong Buy
-12.7% avg upside
29 analysts
|
$92.00
58.50% Downside
|
+34.5% |
|
CNC
Centene
|
Dec 19, 2022 | BUY |
Buy
+8.6% avg upside
28 analysts
|
$106.00
73.75% Upside
|
-8.5% |
|
HUM
Humana
|
Nov 03, 2022 | BUY |
Buy
-11.2% avg upside
34 analysts
|
$635.00
76.15% Upside
|
-14.7% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.